Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cognitive and functional changes with aging in schizophrenia.

J I Friedman1, P D Harvey, E Kemether

  • 1Mount Sinai School of Medicine, Department of Psychiatry, New York, NY 10029, USA.

Biological Psychiatry
|October 6, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Real-world outcomes in patients with ALK-positive non-small cell lung cancer treated with crizotinib.

Current oncology (Toronto, Ont.)·2018
Same author

Economic burden of diagnosed pertussis among individuals with asthma or chronic obstructive pulmonary disease in the USA: an analysis of administrative claims.

Epidemiology and infection·2017
Same author

The histone deacetylase inhibitor givinostat (ITF2357) exhibits potent anti-tumor activity against CRLF2-rearranged BCP-ALL.

Leukemia·2017
Same author

Effect Of Sample Size And Data Maturity On Parametric Survival Modeling Projections In Advanced Cancer.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Dose Titration, Persistence, and Adherence to Statin Therapy Among Patients with High-Risk Vascular Disease in Japan.

Value in health : the journal of the International Society for Pharmacoeconomics and Outcomes Research·2016
Same author

Myelination, oligodendrocytes, and serious mental illness.

Glia·2014

Schizophrenia

Area of Science:

  • Geriatric Psychiatry
  • Neuroscience
  • Schizophrenia Studies

Background:

  • Schizophrenia often presents with cognitive and functional deficits.
  • These deficits can vary significantly in severity and progression throughout a patient's life.
  • Late-life schizophrenia outcomes show considerable heterogeneity.

Purpose of the Study:

  • To review current findings on cognitive and functional changes in aging individuals with schizophrenia.
  • To focus specifically on patients with a poor lifetime functional outcome.
  • To explore the variability in late-life functional outcomes in schizophrenia.

Main Methods:

  • Literature review of existing studies on aging and schizophrenia.
  • Analysis of cognitive and functional changes in late-life schizophrenia.

Related Experiment Videos

  • Examination of neuropathological findings in relation to cognitive decline.

    • Main Results:

    • Functional outcomes in late-life schizophrenia are highly variable.
    • Some patients experience worsening cognitive and functional deficits, while others show stability or improvement.
    • Worsening deficits are more pronounced in those with a history of severe functional impairment.
    • Neuropathological studies do not reveal typical causes for severe cognitive impairments in these patients.

    Conclusions:

    • The aging process in schizophrenia is characterized by diverse functional trajectories.
    • Patients with a poor lifetime functional outcome are at higher risk for significant decline in late life.
    • Further research is needed to understand the underlying mechanisms of cognitive and functional changes in aging schizophrenia patients, particularly those with poor outcomes.